Literature DB >> 15370618

Severe neurotoxicity caused by gemcitabine treatment.

Finn Ole Larsen1, Steen Werner Hansen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15370618     DOI: 10.1080/02841860410018494

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  8 in total

1.  Delayed posterior encephalopathy syndrome following chemotherapy with oxaliplatin and gemcitabine.

Authors:  Germán Morís; Renee Ribacoba; Carmen González
Journal:  J Neurol       Date:  2007-03-04       Impact factor: 4.849

2.  Gemcitabine and cisplatin chemotherapy induced reversible posterior leukoencephalopathy syndrome in a bladder cancer patient.

Authors:  Takahiro Maeda; Eiji Kikuchi; Kazuhiro Matsumoto; Satoshi Yazawa; Jun Hagiuda; Akira Miyajima; Ken Nakagawa; Hirokazu Fujiwara; Haruhiko Hoshino; Mototsugu Oya
Journal:  Int J Clin Oncol       Date:  2010-03-30       Impact factor: 3.402

3.  Neurological variability in chemotherapy-induced posterior reversible encephalopathy syndrome associated with thrombotic microangiopathy: Case reports and literature review.

Authors:  Chen Makranz; Salome Khutsurauli; Yosef Kalish; Ruth Eliahou; Luna Kadouri; John Moshe Gomori; Alexander Lossos
Journal:  Mol Clin Oncol       Date:  2017-11-02

4.  A case of gemcitabine and cisplatin associated posterior reversible encephalopathy syndrome.

Authors:  Eun Jin Kwon; Se Won Kim; Kwang Ki Kim; Hyung Suk Seo; Do Yeun Kim
Journal:  Cancer Res Treat       Date:  2009-03-31       Impact factor: 4.679

5.  Gemcitabine and Cisplatin induced posterior reversible encephalopathy syndrome: A case report with review of literature.

Authors:  Rohit Santosh Kabre; Krishna Marotirao Kamble
Journal:  J Res Pharm Pract       Date:  2016 Oct-Dec

6.  Posterior reversible encephalopathy syndrome (PRES) associated with ovarian cancer and voltage-gated potassium channel antibodies: A case report.

Authors:  Laura K Hadad; Caroline C Billingsley
Journal:  Gynecol Oncol Rep       Date:  2017-03-08

7.  Chemotherapy-induced posterior reversible encephalopathy syndrome: Three case reports.

Authors:  Bernardo Cacho-Díaz; Nydia A Lorenzana-Mendoza; Karen Salmerón-Moreno; Gervith Reyes-Soto; Carlos Castillo-Rangel; Roberto Corona-Cedillo; Salvador Escobar-Ceballos; Jaime G de la Garza-Salazar
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

8.  A case report of posterior reversible encephalopathy syndrome in a patient receiving gemcitabine and cisplatin.

Authors:  Hannah Cherniawsky; Neesha Merchant; Micheal Sawyer; Maria Ho
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.